Get to know our clinical trials

Ensayo de MCLA-158 en cáncer colorrectal metastásico y en otros tumores sólidos avanzados

THIS CLINICAL STUDY WILL EVALUATE THE SAFETY OF MCLA-158 IN PATIENTS WITH METASTATIC COLORECTAL CANCER AND OTHER ADVANCED SOLID TUMORS.

Status
In recruitment
headquarters
Pamplona

Technical Summary

  • PHASE 1 DOSE ESCALATION AND GROUP EXPANSION STUDY IN THE EVALUATION OF SINGLE-AGENT MCLA-158 IN METASTATIC COLORECTAL CANCER AND OTHER ADVANCED SOLID TUMORS
  • Code EudraCT: 2017-004745-24
  • Protocol number: MCLA-158-CL01
  • Promoter: Merus N.V.
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

More information about this clinical trial

Information offered by the Spanish Registry of Clinical Studies

  • Summary
  • Information
  • Calendar
  • Headquarters
  • Drugs

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.